2196 — Shanghai Fosun Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00- HK$37.57bn
- HK$74.30bn
- CNY41.07bn
- 48
- 55
- 61
- 58
Annual income statement for Shanghai Fosun Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30,307 | 39,005 | 43,952 | 41,400 | 41,067 |
| Cost of Revenue | |||||
| Gross Profit | 16,811 | 18,712 | 20,696 | 19,683 | 19,641 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 25,596 | 32,710 | 39,309 | 38,097 | 36,844 |
| Operating Profit | 4,711 | 6,295 | 4,642 | 3,302 | 4,223 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4,678 | 6,054 | 4,574 | 3,265 | 4,169 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3,940 | 4,987 | 3,947 | 2,895 | 3,512 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3,663 | 4,735 | 3,731 | 2,386 | 2,770 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3,663 | 4,735 | 3,731 | 2,386 | 2,770 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.38 | 1.24 | 1.34 | 0.69 | 0.765 |
| Dividends per Share |